Gold nephropathy. An immunopathologic study.
D000936:Antigen-Antibody Complex; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004847:Epithelial Cells; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005455:Fluorescent Antibody Technique; D006046:Gold / Q000009:adverse effects* / Q000032:analysis; D006052:Gold Sodium Thiomalate / Q000009:adverse effects; D006801:Humans; D007072:Immunoglobulin D / Q000032:analysis; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007678:Kidney Glomerulus / Q000276:immunology / Q000473:pathology; D007687:Kidney Tubules, Proximal / Q000032:analysis / Q000473:pathology; D008875:Middle Aged; D009393:Nephritis / Q000139:chemically induced; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D012217:Rheumatoid Factor / Q000032:analysis
D000936:Antigen-Antibody Complex; D007072:Immunoglobulin D; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D006052:Gold Sodium Thiomalate; D007073:Immunoglobulin E; D006046:Gold; D005340:Fibrinogen; D012217:Rheumatoid Factor